Lv5
1028 积分 2023-08-29 加入
Therapeutic landscape and future direction of metastatic colorectal cancer
5个月前
已完结
Adagrasib: First Approval
5个月前
已完结
Targeting KRAS-Mutated Gastrointestinal Malignancies with Small-Molecule Inhibitors: A New Generation of Breakthrough Therapies
5个月前
已完结
A Potent SOS1 PROTAC Degrader with Synergistic Efficacy in Combination with KRASG12C Inhibitor
5个月前
已完结
Targeting KRAS Oncogene for Patients With Colorectal Cancer: A New Step Toward Precision Medicine
5个月前
已完结
Divarasib Plus Cetuximab Is Safe and Has Efficacy in Colorectal Cancer
5个月前
已关闭
Early promising results with the novel KRASG12C inhibitor divarasib
5个月前
已完结
Precision oncology for KRASG12C-mutant colorectal cancer
5个月前
已完结
Targeting Oncogenic RAS Protein
5个月前
已完结
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry
5个月前
已完结
皖公网安备34019202002308
